Onvansertib effectively targets the once “undruggable” KRAS-mutation present in 50% of colorectal cancerNew Podcast

Investor Relations


The JMP Securities Hematology and Oncology Summit
 December 7, 2022
 3:00pm - 3:15pm EST

Cardiff Oncology management will participate in a virtual fireside chat at The JMP Secutities Hematology and Oncology Summit on Wednesday, December 7th from 3:00 - 3:15 Pm ET.

A link to the fireside chat is provided below: